Published July 31, 2026 | Version v1

IMPURITY PROFILING, STRUCTURAL REACTIVITY AND STABILITY CHALLENGES OF FOSFOMYCIN: A CRITICAL REVIEW WITH EMPHASIS ON EPOXIDE INTEGRITY AS A QUALITY DETERMINANT

  • 1. Director, SRS Pharmaceuticals Pvt. Ltd (Research Centre), Mumbai, Maharashtra, India.
  • 2. SRS Pharmaceuticals Pvt. Ltd (Research Centre), Mumbai, Maharashtra, India.

Description

Fosfomycin is a structurally unique phosphonic acid antibiotic widely used for the treatment of urinary tract infections (UTIs), particularly those caused by multidrug-resistant (MDR) pathogens. Unlike conventional β-lactam or glycopeptide antibiotics, fosfomycin exerts bactericidal action through irreversible inhibition of MurA enzyme ((UDP-N-acetylglucosamine enolpyruvyl transferase) via its strained epoxide ring. While its small molecular size and high aqueous solubility offer formulation advantages, the molecule’s inherent chemical reactivity presents significant stability and impurity-related challenges. The integrity of the epoxide moiety is directly linked to therapeutic activity, making impurity profiling a critical quality attribute (CQA).

Files

5 WJPMS 368.pdf

Files (905.3 kB)

Name Size Download all
md5:92f2f04397497e8f0c0a3e3d9d900bd8
905.3 kB Preview Download